Literature DB >> 25223960

Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy.

Shinichi Shirai1, Ichiro Yabe, Takahiro Kano, Yuka Shimizu, Toru Sasamori, Kazunori Sato, Makoto Hirotani, Takayuki Nonaka, Ikuko Takahashi, Masaaki Matsushima, Naoya Minami, Kazuo Nakamichi, Masayuki Saijo, Kanako C Hatanaka, Tohru Shiga, Shinya Tanaka, Hidenao Sasaki.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain caused by the JC virus that occurs mainly in immunocompromised patients. The prognosis is very poor. As the lesion looks like non- specific leukoencephalopathy, making a diagnosis at the early stage is very difficult. We report three PML cases in which there was a mismatch between (11)C-methionine-positron emission tomography (MET-PET) uptake and (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) uptake. All three cases demonstrated the hyper-uptake of MET around the white matter lesions and hypo-uptake of FDG inside the lesions. We speculate that the infection had ended inside the white matter lesions of these patients, while JC virus infection was ongoing around the lesions, resulting in the increase of methionine metabolism, and the glucose metabolism was reduced or intermediate because inflammatory cells infiltrate PML lesions rarely. Two patients who were diagnosed and treated with mefloquine while the JC virus was at a low level in the cerebrospinal fluid are still alive. We suggest the usefulness of MET-PET for the early diagnosis of PML and early treatment with mefloquine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25223960     DOI: 10.1007/s00415-014-7500-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab.

Authors:  Hans-Peter Hartung
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

2.  11C-methionine PET for differential diagnosis of low-grade gliomas.

Authors:  K Herholz; T Hölzer; B Bauer; R Schröder; J Voges; R I Ernestus; G Mendoza; G Weber-Luxenburger; J Löttgen; A Thiel; K Wienhard; W D Heiss
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  (11)C-Methionine positron emission tomography may monitor the activity of encephalitis.

Authors:  Kenji Hirata; Tohru Shiga; Noriyuki Fujima; Osamu Manabe; Reiko Usui; Yuji Kuge; Nagara Tamaki
Journal:  Acta Radiol       Date:  2012-09-19       Impact factor: 1.990

4.  Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.

Authors:  Minako Beppu; Michi Kawamoto; Souichi Nukuzuma; Nobuo Kohara
Journal:  Intern Med       Date:  2012-05-15       Impact factor: 1.271

5.  Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant.

Authors:  Shuji Kishida; Kozue Tanaka
Journal:  Intern Med       Date:  2010-11-15       Impact factor: 1.271

6.  [A case of progressive multifocal leukoencephalopathy with methionine uptake demonstrated by PET].

Authors:  H Ochi; T Yamada; H Hara; T Yoshimura; T Iwaki; K Nagashima; Y Yogo; T Kobayashi
Journal:  Rinsho Shinkeigaku       Date:  1996-07

Review 7.  Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease.

Authors:  Yukiko Shishido-Hara
Journal:  Acta Neuropathol       Date:  2010-05-13       Impact factor: 17.088

  7 in total
  2 in total

1.  PET Imaging of 18F-FDG, 11C-methionine, 11C-flumazenil, and 11C-4DST in Progressive Multifocal Leukoencephalopathy.

Authors:  Kenji Ishibashi; Yoshiharu Miura; Ken Matsumura; Yusuke Kanemasa; Kazuo Nakamichi; Masayuki Saijo; Jun Toyohara; Kenji Ishii
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

Review 2.  The Use of Antimalarial Drugs against Viral Infection.

Authors:  Sarah D'Alessandro; Diletta Scaccabarozzi; Lucia Signorini; Federica Perego; Denise P Ilboudo; Pasquale Ferrante; Serena Delbue
Journal:  Microorganisms       Date:  2020-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.